Literature DB >> 5024724

Effect of spironolactone on stool electrolyte losses during human cholera.

R L Guerrant, L C Chen, J E Rohde.   

Abstract

This study demonstrated that endogenous aldosterone, as determined by its transient competitive block by spironolactone, caused significant sodium and chloride retention during naturally acquired cholera. This beneficial effect of the hormone is accompanied, however, by a deleterious depletion of potassium. In addition, it was found that stool rate significantly altered the sodium and potassium concentrations in cholera stool despite minimal or absent aldosterone activity.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5024724      PMCID: PMC1412119          DOI: 10.1136/gut.13.3.197

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  RENAL TUBULAR EFFECTS OF HYDROCORTISONE AND ALDOSTERONE IN NORMAL HYDROPENIC MAN: COMMENT ON SITES OF ACTION.

Authors:  S L YUNIS; D D BERCOVITCH; R M STEIN; M F LEVITT; M H GOLDSTEIN
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  ON THE MECHANISM OF ACTION OF ALDOSTERONE ON SODIUM TRANSPORT: THE ROLE OF RNA SYNTHESIS.

Authors:  G A PORTER; R BOGOROCH; I S EDELMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  Evidence for secretion of an aldosterone-stimulating hormone by the kidney.

Authors:  J O DAVIS; C C CARPENTER; C R AYERS; J E HOLMAN; R C BAHN
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

4.  The action of hydroflumethiazide in relation to adrenal steroids and potassium loss.

Authors:  C J EDMONDS; G M WILSON
Journal:  Lancet       Date:  1960-03-05       Impact factor: 79.321

5.  Influence of the endocrine glands on small intestine absorption.

Authors:  A M Gelb; C D Gerson
Journal:  Am J Clin Nutr       Date:  1969-03       Impact factor: 7.045

6.  Factors affecting mucosal water and sodium transfer in everted sacs of rat jejunum.

Authors:  A D Crocker; K A Munday
Journal:  J Physiol       Date:  1969-06       Impact factor: 5.182

7.  Action of aldosterone upon the intestinal transport of potassium, sodium, and water.

Authors:  R Shields; A T Mulholland; R G Elmslie
Journal:  Gut       Date:  1966-12       Impact factor: 23.059

8.  Blocking by spironolactone (SC 9420) of the action of aldosterone upon the intestinal transport of potassium, sodium, and water.

Authors:  R G Elmslie; A T Mulholland; R Shields
Journal:  Gut       Date:  1966-12       Impact factor: 23.059

9.  Water and electrolyte losses due to cholera in infants and small children: a recovery balance study.

Authors:  D Mahalanabis; C K Wallace; R J Kallen; A Mondal; N F Pierce
Journal:  Pediatrics       Date:  1970-03       Impact factor: 7.124

10.  Intestinal fluid and electrolyte transport in human cholera.

Authors:  J G Banwell; N F Pierce; R C Mitra; K L Brigham; G J Caranasos; R I Keimowitz; D S Fedson; J Thomas; S L Gorbach; R B Sack; A Mondal
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

View more
  5 in total

Review 1.  Colonic potassium handling.

Authors:  Mads V Sorensen; Joana E Matos; Helle A Praetorius; Jens Leipziger
Journal:  Pflugers Arch       Date:  2010-02-10       Impact factor: 3.657

2.  Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.

Authors:  H H Wenzl; K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

3.  Idiopathic chronic watery diarrhea from excluded rectosigmoid with goblet cell hyperplasia cured by restoration of large bowel continuity.

Authors:  C Bories; B Miazza; A Galian; P Hautefeuille; G Madesclaire; A Lavergne; J C Rambaud
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

4.  Use of Aldosterone Antagonist to Treat Diarrhea and Hypokalemia of Ogilvie's Syndrome.

Authors:  Pradhum Ram; Abhinav Goyal; Marvin Lu; Joshua Sloan; William McElhaugh
Journal:  Case Rep Gastrointest Med       Date:  2016-10-12

5.  Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

Authors:  Amit Langote; Swapnil Hiremath; Marcel Ruzicka; Brendan B McCormick
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.